Element Wealth LLC lifted its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 394.8% during the fourth quarter, Holdings Channel reports. The firm owned 65,740 shares of the company’s stock after buying an additional 52,454 shares during the period. Element Wealth LLC’s holdings in Teva Pharmaceutical Industries were worth $686,000 […]
Element Wealth LLC increased its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 394.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 65,740 shares of the company’s stock after purchasing an additional 52,454 shares during the quarter. Element Wealth […]
JPMorgan Chase & Co. upgraded shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) from an underweight rating to a neutral rating in a research report report published on Friday, Marketbeat Ratings reports. They currently have $14.00 price objective on the stock. TEVA has been the subject of a number of other reports. HSBC began […]
Saba Capital Management L.P. decreased its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 25.2% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 189,003 shares of the company’s stock after selling 63,835 shares during the period. Saba Capital Management L.P.’s holdings […]
Nordea Investment Management AB decreased its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 59.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 87,615 shares of the company’s stock after selling 130,573 shares during the quarter. Nordea Investment […]